InvestorsHub Logo
Followers 0
Posts 59
Boards Moderated 0
Alias Born 03/26/2013

Re: None

Thursday, 05/08/2014 9:46:12 PM

Thursday, May 08, 2014 9:46:12 PM

Post# of 48316
Immunotherapy gaining more mainstream exposure. Companies like ONCS and INO are on the forefront and will be leaders in the field in the coming years. I'm loaded up on both and plan to retire early in 5 years with the proceeds from this revolutionary shift in how diseases like cancer are treated.

http://www.nytimes.com/2014/05/09/health/doctors-use-patients-immune-cells-to-shrink-cancer-tumors.html?hp&_r=1